News About: Pharm. Industry
Uncertainties lingers in pharmaceutical industry
In recent years, uncertainty has tended to increase in Korea’s pharmaceutical industry as a result of the government’s campaign to lower drug prices and due to the rampant use of illegal rebates.
To lower drug pric...
NTS get tougher over tax evasion
Korean tax authorities imposed 83.8 billion won in punitive taxes on 30 healthcare providers.
The National Tax Service said that it also plans to refer eight of the 30 companies that profiteered the most from the u...
Wholesalers likely to boycott locally manufactured medicines
Pharmaceutical wholesalers have threatened to boycott products of local drugmakers, reflecting their anger over lukewarm response of the controversial unified distribution issue in local pharmaceutical industry.
Th...
Hanmi’s sales dipped in second quarter
Hanmi Pharm said on July 13 that its second-quarter revenues recorded 150.1 billion won, down 4.5 percent from the same period of the previous year due to influence of sluggish sales in clinics.
Net income amounted...
Individual investors acquire 30% stake in Wooridul Pharm
Wooridul Pharm said in its regulatory filing on July 6 that a group of individual investors bought 30% stake in Wooridul Pharm to jump into hospital related business sectors.
The individual investor group, led by P...
Korean drugmakers urged to nurture marketing experts
The healthcare and biopharmaceutical industries may have been designated as two of the new growth engines for the Korean economy, but there are still faces many challenges to overcome, such as a lack of marketing expe...
Biosimilars fever hits snag
Korea’s policymakers dreamed that biosimilars are poised to exploit the opportunity arising from expiring marketing exclusivity on the leading blockbuster biologics in Korea.
However, the biologics environment is a...
Lilly Korea, Handok to copromote Cialis
Lilly Korea and Handok Pharm announced on July 12 that they entered into a letter of intent to comarket Cialis (tadalafil) in the domestic impotence market, following their strategic alliances over Cymbalta.
Cialis...
CJ, Alteogen sign MOU on human GH research
CJ Cheil Jedang and Alteogen Inc., a local biopharmaceutical firm signed a memorandum of understanding on July 9 to collaborate on joint projects and on the research and development of a novel human growth hormone (GH...
Korea Eximbank to support hidden champions
The Export-import Bank of Korea (Korea Eximbank) plans to nurture 300 hidden champions with high potential, to become competitive global players by 2020.
Eximbank has played a leading role in tackling the issue by ...
